Form 4: Personalis CEO Sells Shares Under 10b5-1 Plan

Personalis CEO Christopher M. Hall reported the sale of 100,000 shares of common stock, acquired through option exercise, as part of a pre-arranged trading plan.

Summary

• Christopher M. Hall, CEO of Personalis, Inc., executed a transaction on June 26, 2026, involving the sale of 100,000 shares of common stock.
• These shares were acquired through the exercise of stock options.
• The transaction was conducted under a Rule 10b5-1 trading plan adopted on December 17, 2025.
• The weighted average sale price for these shares was $13.15, with individual sales ranging from $13.00 to $13.36.
• Following the sale, Hall beneficially owns 235,986 shares of common stock directly.

Sentiment

Score: 4

Explanation: StockSavvy.ai views this as a neutral to slightly negative event due to the significant sale by the CEO, although mitigated by the use of a 10b5-1 plan.

Positives

• The sale was executed under a Rule 10b5-1 plan, indicating pre-planned and potentially less market-impactful trading.
• The CEO continues to hold a significant number of shares (235,986) after the transaction.

Negatives

• A substantial number of shares (100,000) were sold by the CEO.

Risks

• Potential for negative market perception due to a significant sale by the CEO, even if executed under a 10b5-1 plan.
• The stock price range of sales ($13.00-$13.36) may indicate a point of resistance or a level at which the CEO found it opportune to divest.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding future financial performance or strategic initiatives.

Management Comments

• The sales and option exercise reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 17, 2025.
• The price reported above reflects the weighted average price of the shares sold. The sale price ranged from $13.00 to $13.36 per share. Upon request from the SEC staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
• The option vested and became exercisable over the three-year period commencing April 15, 2024, with 1/36th of the shares subject to the option vesting each month of continuous service thereafter.

Industry Context

StockSavvy.ai notes that insider sales, particularly by CEOs, are common events. The use of a Rule 10b5-1 plan is a standard practice to mitigate concerns about insider trading, allowing executives to diversify holdings or manage personal finances in a structured manner. The volume of shares sold relative to the CEO's total holdings and the company's market capitalization will be key factors in assessing market impact.

Stakeholder Impact

• Shareholders: May perceive the sale as a negative signal, although the 10b5-1 plan provides some reassurance. The continued direct ownership of over 235,000 shares suggests ongoing commitment.
• Employees: May be influenced by the CEO's stock sales, potentially impacting morale if viewed negatively.
• Management: The transaction is a routine part of executive compensation and financial planning.

Next Steps

• Monitor future Form 4 filings for any additional transactions by Christopher M. Hall or other insiders.
• Observe the company's stock performance following this transaction and any related market commentary.

Key Dates

Recommendation

The filing reports a significant sale of stock by the CEO under a pre-arranged 10b5-1 plan. While insider selling can be a negative signal, the structured nature of the sale and the CEO's substantial remaining ownership suggest this is likely part of personal financial planning rather than a reflection of negative company outlook. Therefore, a 'hold' recommendation is appropriate pending further company performance data.

Keywords

Personalis, PSNL, Form 4, Insider Trading, Stock Sale, 10b5-1 Plan, CEO, Stock Options, Beneficial Ownership